Tower Research Capital LLC (Trc) Moon Lake Immunotherapeutics Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 47 shares of MLTX stock, worth $2,256. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47
Previous 279
83.15%
Holding current value
$2,256
Previous $14,000
85.71%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MLTX
# of Institutions
129Shares Held
58.2MCall Options Held
103KPut Options Held
79.7K-
Bvf Inc San Francisco, CA21.8MShares$1.04 Billion29.25% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$408 Million28.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$133 Million1.66% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.56MShares$123 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.27MShares$109 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.77B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...